Ayman Mokhtar

Ayman Mokhtar is the Regional President for the Middle East, North Africa, and Eurasia at Viatris, a global healthcare company. He has extensive experience in the field of cardiovascular diseases, focusing on prevention, risk management, and treatment of complex cases. His recent involvement in the UAE's approval of the innovative heart failure treatment 'Inbifa' (sotagliflozin) highlights his commitment to improving patient care and enhancing the quality of life for those suffering from heart conditions.